• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺乏重链特定结构域的人组织型纤溶酶原激活剂变体。

Variants of human tissue-type plasminogen activator that lack specific structural domains of the heavy chain.

作者信息

Gething M J, Adler B, Boose J A, Gerard R D, Madison E L, McGookey D, Meidell R S, Roman L M, Sambrook J

机构信息

Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas 75235.

出版信息

EMBO J. 1988 Sep;7(9):2731-40. doi: 10.1002/j.1460-2075.1988.tb03127.x.

DOI:10.1002/j.1460-2075.1988.tb03127.x
PMID:2846282
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC457063/
Abstract

The heavy chain of tissue plasminogen activator (t-PA) consists of four domains [finger, epidermal-growth-factor (EGF)-like, kringle 1 and kringle 2] that are homologous to similar domains present in other proteins. To assess the contribution of each of the domains to the biological properties of the enzyme, site-directed mutagenesis was used to generate a set of mutants lacking sequences corresponding to the axons encoding the individual structural domains. The mutant proteins were assayed for their ability to hydrolyze artificial and natural substrates in the presence and absence of fibrin, to bind to lysine-Sepharose and to be inhibited by plasminogen activator inhibitor-1. All the deletion mutants exhibit levels of basal enzymatic activity very similar to that of wild-type t-PA assayed in the absence of fibrin. A mutant protein lacking the finger domain has a 2-fold higher affinity for plasminogen than wild-type t-PA, while the mutant that lacks both finger and EGF-like domains is less active at low concentrations of plasminogen. Mutants lacking both kringles neither bind to lysine-Sepharose nor are stimulated by fibrin. However, mutants containing only one kringle (either kringle 1 or kringle 2) behave indistinguishably from one another and from the wild-type protein. We conclude that kringle 1 and kringle 2 are equivalent in their ability to mediate stimulation of catalytic activity by fibrin.

摘要

组织型纤溶酶原激活物(t-PA)的重链由四个结构域组成[指状结构域、表皮生长因子(EGF)样结构域、kringle 1和kringle 2],这些结构域与其他蛋白质中存在的类似结构域同源。为了评估每个结构域对该酶生物学特性的贡献,采用定点诱变技术构建了一组突变体,这些突变体缺失了与编码各个结构域的序列相对应的片段。对突变蛋白进行了检测,以评估它们在有无纤维蛋白存在的情况下水解人工和天然底物的能力、与赖氨酸-琼脂糖的结合能力以及被纤溶酶原激活物抑制剂-1抑制的能力。所有缺失突变体在无纤维蛋白存在时检测到的基础酶活性水平与野生型t-PA非常相似。缺失指状结构域的突变蛋白对纤溶酶原的亲和力比野生型t-PA高2倍,而同时缺失指状结构域和EGF样结构域的突变体在低浓度纤溶酶原时活性较低。缺失两个kringle结构域的突变体既不与赖氨酸-琼脂糖结合,也不受纤维蛋白刺激。然而,仅含有一个kringle结构域(kringle 1或kringle 2)的突变体之间以及与野生型蛋白之间的行为没有区别。我们得出结论,kringle 1和kringle 2在介导纤维蛋白对催化活性的刺激能力方面是等效的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efc5/457063/098d119eec8b/emboj00146-0106-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efc5/457063/2b3256bae4e6/emboj00146-0105-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efc5/457063/098d119eec8b/emboj00146-0106-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efc5/457063/2b3256bae4e6/emboj00146-0105-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efc5/457063/098d119eec8b/emboj00146-0106-a.jpg

相似文献

1
Variants of human tissue-type plasminogen activator that lack specific structural domains of the heavy chain.缺乏重链特定结构域的人组织型纤溶酶原激活剂变体。
EMBO J. 1988 Sep;7(9):2731-40. doi: 10.1002/j.1460-2075.1988.tb03127.x.
2
Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator.组织型纤溶酶原激活剂与尿激酶型纤溶酶原激活剂杂交体中的结构域间相互作用
Protein Eng. 1995 Dec;8(12):1295-1302. doi: 10.1093/protein/8.12.1295.
3
Replacement of finger and growth factor domains of tissue plasminogen activator with plasminogen kringle 1. Biochemical and pharmacological characterization of a novel chimera containing a high affinity fibrin-binding domain linked to a heterologous protein.用纤溶酶原kringle 1替换组织型纤溶酶原激活剂的手指和生长因子结构域。一种含有与异源蛋白相连的高亲和力纤维蛋白结合结构域的新型嵌合体的生化和药理学特性。
J Biol Chem. 1991 Feb 25;266(6):3715-23.
4
Structure and function of human tissue-type plasminogen activator (t-PA).人组织型纤溶酶原激活剂(t-PA)的结构与功能
J Cell Biochem. 1986;32(3):169-78. doi: 10.1002/jcb.240320302.
5
On the interaction of the finger and the kringle-2 domain of tissue-type plasminogen activator with fibrin. Inhibition of kringle-2 binding to fibrin by epsilon-amino caproic acid.关于手指结构域及组织型纤溶酶原激活物的kringle-2结构域与纤维蛋白的相互作用。ε-氨基己酸对kringle-2与纤维蛋白结合的抑制作用。
J Biol Chem. 1986 Oct 25;261(30):14214-8.
6
Variants of human tissue-type plasminogen activator. Fibrin binding, fibrinolytic, and fibrinogenolytic characterization of genetic variants lacking the fibronectin finger-like and/or the epidermal growth factor domains.人组织型纤溶酶原激活剂的变体。缺乏纤连蛋白指状结构域和/或表皮生长因子结构域的基因变体的纤维蛋白结合、纤维蛋白溶解和纤维蛋白原溶解特性。
J Biol Chem. 1988 Jan 15;263(2):1023-9.
7
Autonomous functions of structural domains on human tissue-type plasminogen activator.人组织型纤溶酶原激活剂结构域的自主功能
Proc Natl Acad Sci U S A. 1986 Jul;83(13):4670-4. doi: 10.1073/pnas.83.13.4670.
8
Biochemical and functional characterization of human tissue-type plasminogen activator variants with mutagenized kringle domains.具有诱变 kringle 结构域的人组织型纤溶酶原激活剂变体的生化和功能特性
J Biol Chem. 1990 Jul 25;265(21):12184-91.
9
The position of the structurally autonomous kringle 2 domain influences the functional features of tissue-type plasminogen activator.结构自主的kringle 2结构域的位置影响组织型纤溶酶原激活剂的功能特性。
Protein Eng. 1995 Mar;8(3):293-300. doi: 10.1093/protein/8.3.293.
10
Involvement of finger domain and kringle 2 domain of tissue-type plasminogen activator in fibrin binding and stimulation of activity by fibrin.组织型纤溶酶原激活物的指状结构域和kringle 2结构域参与纤维蛋白结合及纤维蛋白对其活性的刺激作用。
EMBO J. 1986 Dec 20;5(13):3525-30. doi: 10.1002/j.1460-2075.1986.tb04678.x.

引用本文的文献

1
Development and Testing of Thrombolytics in Stroke.溶栓药物在中风治疗中的研发与测试。
J Stroke. 2021 Jan;23(1):12-36. doi: 10.5853/jos.2020.03349. Epub 2021 Jan 31.
2
Production of Bioactive Recombinant Reteplase by Virus-Based Transient Expression System in .基于病毒的瞬时表达系统在……中生产生物活性重组瑞替普酶
Front Plant Sci. 2019 Oct 8;10:1225. doi: 10.3389/fpls.2019.01225. eCollection 2019.
3
Structural Biology and Protein Engineering of Thrombolytics.溶栓剂的结构生物学与蛋白质工程

本文引用的文献

1
Domain structure of hamster plasma fibronectin. Isolation and characterization of four functionally distinct domains and their unequal distribution between two subunit polypeptides.仓鼠血浆纤连蛋白的结构域。四个功能不同结构域的分离与特性,以及它们在两条亚基多肽之间的不均等分布。
J Biol Chem. 1981 Jun 25;256(12):6452-62.
2
Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator.单链和双链人外源性(组织型)纤溶酶原激活剂的纤维蛋白溶解特性
J Biol Chem. 1982 Mar 25;257(6):2920-5.
3
Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.
Comput Struct Biotechnol J. 2019 Jul 2;17:917-938. doi: 10.1016/j.csbj.2019.06.023. eCollection 2019.
4
A continuous-exchange cell-free protein synthesis system based on extracts from cultured insect cells.一种基于培养昆虫细胞提取物的连续交换无细胞蛋白质合成系统。
PLoS One. 2014 May 7;9(5):e96635. doi: 10.1371/journal.pone.0096635. eCollection 2014.
5
Tissue plasminogen activator mediates microglial activation via its finger domain through annexin II.组织型纤溶酶原激活剂通过膜联蛋白II经其指状结构域介导小胶质细胞活化。
J Neurosci. 2002 May 1;22(9):3352-8. doi: 10.1523/JNEUROSCI.22-09-03352.2002.
6
Calnexin and calreticulin bind to enzymically active tissue-type plasminogen activator during biosynthesis and are not required for folding to the native conformation.钙联结蛋白和钙网蛋白在生物合成过程中与具有酶活性的组织型纤溶酶原激活剂结合,并且对于折叠成天然构象并非必需。
Biochem J. 1997 Nov 15;328 ( Pt 1)(Pt 1):113-9. doi: 10.1042/bj3280113.
7
Decreased extracellular deposition of fibrillin and decorin in neonatal Marfan syndrome fibroblasts.新生儿马凡综合征成纤维细胞中纤连蛋白和核心蛋白聚糖的细胞外沉积减少。
Hum Genet. 1993 Jan;90(5):511-5. doi: 10.1007/BF00217450.
8
Muscle-specific trk-related receptor with a kringle domain defines a distinct class of receptor tyrosine kinases.具有kringle结构域的肌肉特异性trk相关受体定义了一类独特的受体酪氨酸激酶。
Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2895-9. doi: 10.1073/pnas.90.7.2895.
9
Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen.组织型纤溶酶原激活剂(tPA)抑制纤溶酶对纤维蛋白的降解。该机制可减缓tPA介导的纤维蛋白溶解,但不需要α2-抗纤溶酶或内源性纤溶酶原的泄漏。
J Clin Invest. 1995 Jun;95(6):2483-90. doi: 10.1172/JCI117949.
10
Binding of plasminogen activators to fibrin: characterization and pharmacological consequences.纤溶酶原激活剂与纤维蛋白的结合:特性及药理学后果
Biochem J. 1989 Jul 15;261(2):313-24. doi: 10.1042/bj2610313.
人组织型纤溶酶原激活物激活纤溶酶原的动力学。纤维蛋白的作用。
J Biol Chem. 1982 Mar 25;257(6):2912-9.
4
Purification and identification of two structural variants of porcine tissue plasminogen activator by affinity adsorption on fibrin.通过纤维蛋白亲和吸附纯化和鉴定猪组织型纤溶酶原激活剂的两种结构变体
Biochim Biophys Acta. 1982 Nov 24;719(2):318-28. doi: 10.1016/0304-4165(82)90105-2.
5
Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture.培养的人黑色素瘤细胞分泌的纤溶酶原激活物的纯化及特性分析
J Biol Chem. 1981 Jul 10;256(13):7035-41.
6
Common evolutionary origin of the fibrin-binding structures of fibronectin and tissue-type plasminogen activator.纤连蛋白和组织型纤溶酶原激活物的纤维蛋白结合结构的共同进化起源。
FEBS Lett. 1983 Oct 31;163(1):37-41. doi: 10.1016/0014-5793(83)81157-0.
7
Computer-based characterization of epidermal growth factor precursor.基于计算机的表皮生长因子前体特征分析
Nature. 1984;307(5951):558-60. doi: 10.1038/307558a0.
8
Characterization of a cDNA coding for human protein C.编码人蛋白C的cDNA的特性分析。
Proc Natl Acad Sci U S A. 1984 Aug;81(15):4766-70. doi: 10.1073/pnas.81.15.4766.
9
Identification and primary sequence of an unspliced human urokinase poly(A)+ RNA.未剪接的人尿激酶聚腺苷酸加尾RNA的鉴定及一级序列
Proc Natl Acad Sci U S A. 1984 Aug;81(15):4727-31. doi: 10.1073/pnas.81.15.4727.
10
Characterization of a cDNA coding for human factor X.编码人凝血因子X的cDNA的特性分析
Proc Natl Acad Sci U S A. 1984 Jun;81(12):3699-702. doi: 10.1073/pnas.81.12.3699.